# US 2026/0096978 A1 · A method for preventing, mitigating and/or treating ptgs2-induced skin disorders and related dysfunctions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0096978 A1
- Document ID: US20260096978A1
- Status: Published application
- Kind: A1
- Application number: 19/110,636
- Filed: 2022-11-14
- Published: 2026-04-09
- Earliest claimed: 2022-09-19
- Applicants: Symrise AG
- Inventors: Dominik STUHLMANN; Maria REICHENBACH; Paul SLAVASHEVICH; Christina GIRARDI; Michele MASSIRONI
- Web page: https://patentgrep.com/patent/US20260096978A1

## CPC

- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 31/4172: Imidazole-alkanecarboxylic acids, e.g. histidine
- A61K 38/05: Dipeptides
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Suggested is a non-therapeutic method for preventing, mitigating or treating PTGS2-induced disorders of human skin and related dysfunctions, comprising or consisting of the following step: —applying a working amount of a carnosine compound according to formula (I) in which R1 stands for H or CH3 and R2 for H or COOH, to human skin

## Claims

### Claim 1

A non-therapeutic method for preventing, mitigating or treating PTGS2-induced disorders of human skin and related dysfunctions, comprising or consisting of the following step:
applying a working amount of a carnosine compound according to formula (I)
in which R1 stands for H or CH3 and R2 for H or COOH, to human skin

### Claim 2 (depends on 1)

The method of claim 1, wherein the skin disorder is inflammation, ageing and/or skin cancer.

### Claim 3 (depends on 1)

The method of claim 1, wherein the dysfunction is fever and/or pain.

### Claim 4 (depends on 1)

The method of claim 1, wherein said carnosine compound is selected from the group consisting of Carnosine, L-Carnosine, D-Carnosine, D/L-Carnosine, Anserine, D-Anserine, L-Anserine, L-Anserine*HNO3 and mixtures thereof.

### Claim 5 (depends on 1)

The method of claim 1, wherein said carnosine compound is L-Carnosine.

### Claim 6 (depends on 1)

The method of claim 1, wherein said carnosine compound is applied to human skin as a component of a cosmetic skin or sun care formulation.

### Claim 7 (depends on 6)

The method of claim 6, wherein said cosmetic formulation is a cream, a lotion, an ointment or a spray.

### Claim 8 (depends on 6)

The method of claim 6, wherein said carnosine compounds are present in said cosmetic formulations in amounts of from about 0.01 to about 5 wt.—percent—calculated on the formulation.

### Claim 9 (depends on 6)

The method of claim 6, wherein said cosmetic formulations further contain at least one primary and/or secondary sun protection filter.

### Claim 10

Carnosine compounds according to formula (I) as medicaments for preventing, mitigating and/or treating disorders of human skin or related dysfunctions induced by enhanced expression of PTGS2.

### Claim 11 (depends on 10)

Compounds for use according to claim 10, wherein said compound is L-Carnosine.

### Claim 12 (depends on 1)

Compounds for use according to claim 1, wherein said skin disorders are selected from inflammation, ageing and/or skin cancer.

### Claim 13 (depends on 1)

Compounds for use according to claim 1, wherein said related dysfunctions are selected from fever and/or pain.

### Claim 14 (depends on 1)

Compounds for use according to claim 1, wherein said carnosines are formulated in a cream, a lotion, an ointment or a spray.

### Claim 15

A carnosine compound according to formula (I)
in which R1 stands for H or CH3 and R2 for H or COOH, for use as a medicament for preventing, mitigating or treating PTGS2-induced disorders of human skin and related dysfunctions
